Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Brain tumor Stories

2014-03-07 23:00:56

iewei Ltd. solution starts at the base, raising awareness by making the invisible pollution visible — that is what iewei, the wellness wristband is all about. It is an “alert system” capable of measuring the wearer’s exposure to harmful radiation, in addition to monitoring heart rate and body temperature. (PRWEB) March 07, 2014 For the network operators 'Greed is good' was a phrase immortalized by Michael Douglas' in his Oscar-winning turn as the unscrupulous corporate...

2014-03-06 23:02:20

Running Program Recruiting for 2014 Bank of America Chicago Marathon Chicago, IL (PRWEB) March 06, 2014 As an official Bank of America Chicago Marathon Charity Partner, the American Brain Tumor Association’s endurance program, Team Breakthrough, has a limited number of guaranteed entries available for the marathon. Participants who register with Team Breakthrough receive their race entry, a comprehensive training plan with Chicago Endurance Sports, a personal Team Breakthrough...

2014-03-06 08:29:14

NEW YORK, March 6, 2014 /PRNewswire/ -- SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), a biotechnology company focused on proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The note is focuses on DelMar Pharmaceuticals...

2014-03-05 23:03:44

Project Impact aims to fundamentally change the way new pediatric cancer therapies are developed and tested, through public policy and a funded research program. Boston, MA (PRWEB) March 05, 2014 National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, today announced the launch of Project Impact: Driving Discovery to a Cure for Pediatric Brain Tumors, an integrated research and drug development program that seeks to confront the...

2014-03-05 08:29:16

Lung, Prostate, and Brain Cancer Patients Receive Edge Radiosurgery at Champalimaud Center for the Unknown LISBON, Portugal, March 5, 2014 /PRNewswire/ -- Doctors at the Champalimaud Center for the Unknown here have performed the world's first cancer treatments using the new advanced Edge(TM) radiosurgery system from Varian Medical Systems (NYSE: VAR). This fast, precise and non-invasive alternative to conventional surgery was used to treat several patients with lung, prostate and...

2014-03-04 08:31:55

VANCOUVER, British Columbia and MENLO PARK, Calif., March 4, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") a pharmaceutical company developing its VAL-083 chemotherapy as a potential new therapy for glioblastoma multiforme, today announced that Jeffrey A. Bacha, President and CEO of DelMar Pharmaceuticals, Inc., will present at the upcoming 26(th) Annual ROTH Capital Conference. Mr. Bacha will make a corporate presentation to...

2014-02-27 23:32:09

New treatment center is first of its kind in the nation. St. Louis, MO (PRWEB) February 27, 2014 This month, brain tumor patient Charlie North became the first patient at St. Louis Children’s Hospital to undergo proton beam therapy, a type of radiation that holds great promise for pediatric patients. In late November of last year, Julia and Jake North of Paris, Ill., had their lives turned upside down when they received news that Charlie, the oldest of their 6-year-old triplets, had a...

2014-02-26 23:02:51

Jumpstarting Brain Tumor Drug Development Coalition hosts seminal workshop with brain tumor patient advocates, leading neuro-oncologists, biopharmaceutical industry representatives, FDA, and NCI to advance strategies for establishing better pathways for therapy evaluation. Bethesda, MD (PRWEB) February 26, 2014 Leaders from key cross-sections of the neuro-oncology community came together at a recent Brain Tumor Clinical Trial Endpoints Workshop to confront a critical challenge in...

New Imaging System Lights Up Tumors Using Scorpion Venom Protein And Laser
2014-02-26 10:42:27

Cedars-Sinai Medical Center Cedars-Sinai animal study may lead to human trial of experimental, compact intraoperative device to aid removal of malignant brain tumors Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery have developed a unique, compact, relatively inexpensive imaging device to "light up" malignant brain tumors and other cancers. The experimental system consists of a special camera designed and developed at Cedars-Sinai...

2014-02-26 08:28:38

Interim clinical data to be presented at American Association of Cancer Research (AACR) Annual Meeting on April 9, 2014 VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 26, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update on the company's ongoing Phase I/II clinical trial for VAL-083 in recurrent glioblastoma (GBM). DelMar has completed enrollment of VAL-083 dose Cohort 5 and advanced to Cohort 6. DelMar...